Drug Pipeline

Infanrix hexa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07160244
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women…		 Trial sites expanded: 179 -> 198 locations
2026-05-30 NCT07160244
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women…		 Primary endpoint(s) modified
2026-05-15 NCT07160244
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women…		 Trial sites expanded: 165 -> 177 locations
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07160244 BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women… Healthy Recruiting
Phase 2
NCT07320716 Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children Diarrhoea Not Yet Recruiting
Phase 1/2
NCT06647407 Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine… Meningococcal Immunization Active, Not Recruiting
Sponsors Running Infanrix hexa Trials
Sanofi Pasteur, a Sanofi Company (1) Pfizer (1) GlaxoSmithKline (1)
Get alerts when Infanrix hexa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free